CenterBook Partners’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,905
| Closed | -$1.49M | – | 451 |
|
|
2024
Q2 | $1.49M | Buy |
+10,905
| New | +$1.49M | 0.09% | 296 |
|
|
2024
Q1 | – | Sell |
-5,207
| Closed | -$656K | – | 381 |
|
|
2023
Q4 | $656K | Sell |
5,207
-4,317
| -45% | -$544K | 0.08% | 300 |
|
|
2023
Q3 | $892K | Sell |
9,524
-13,615
| -59% | -$1.27M | 0.11% | 260 |
|
|
2023
Q2 | $2.07M | Buy |
23,139
+16,864
| +269% | +$1.51M | 0.26% | 131 |
|
|
2023
Q1 | $673K | Sell |
6,275
-2,915
| -32% | -$313K | 0.1% | 285 |
|
|
2022
Q4 | $1.12M | Buy |
9,190
+6,636
| +260% | +$810K | 0.18% | 184 |
|
|
2022
Q3 | $264K | Sell |
2,554
-1,549
| -38% | -$160K | 0.05% | 349 |
|
|
2022
Q2 | $381K | Buy |
+4,103
| New | +$381K | 0.08% | 300 |
|